Lake B G, Price R J, Cunninghame M E, Walters D G
BIBRA International, Carshalton, Surrey, UK.
Toxicology. 1997 Dec 5;123(3):217-26. doi: 10.1016/s0300-483x(97)00125-x.
The effects of di-(2-ethylhexyl)adipate (DEHA) have been compared in female F344 rats and female B6C3F1 mice fed diets containing 0-4.0% DEHA and 0-2.5% DEHA, respectively, for periods of 1, 4 and 13 weeks. In both the rat and mouse treatment with DEHA at all time points produced a dose-dependent increase in relative liver weight and hepatic peroxisome proliferation as demonstrated by the induction of peroxisomal (cyanide-insensitive palmitoyl-CoA oxidation) and microsomal (lauric acid 12-hydroxylase) fatty acid oxidising enzyme activities. The magnitude of induction of peroxisome proliferation was similar in both species. Replicative DNA synthesis was studied by implanting osmotic pumps containing 5-bromo-2'-deoxyuridine during study weeks 0-1, 3-4 and 12-13. After 1 week DEHA treatment hepatocyte labelling index values were increased in rats given 2.5 and 4.0% DEHA and mice given 0.6-2.5% DEHA. While DEHA treatment for 4 and 13 weeks did not increase labelling index values in the rat, a sustained stimulation of replicative DNA synthesis was observed in mice given 1.2 and 2.5% DEHA. The results of this study demonstrate a species difference in the hepatic effects of DEHA, in that at some dose levels DEHA can produce a sustained stimulation of replicative DNA synthesis in mouse but not in rat liver. Sustained cell replication provides a better correlation with the observed formation of liver tumours in chronic studies with DEHA in female mice, but not in female rats, than the magnitude of stimulation of hepatic peroxisome proliferation.
已对雌性F344大鼠和雌性B6C3F1小鼠进行了比较,分别给它们喂食含0 - 4.0%己二酸二(2 - 乙基己基)酯(DEHA)和0 - 2.5% DEHA的饲料,持续1、4和13周。在大鼠和小鼠中,在所有时间点用DEHA处理均导致相对肝脏重量和肝脏过氧化物酶体增殖呈剂量依赖性增加,这通过过氧化物酶体(氰化物不敏感的棕榈酰辅酶A氧化)和微粒体(月桂酸12 - 羟化酶)脂肪酸氧化酶活性的诱导得以证明。两个物种中过氧化物酶体增殖的诱导程度相似。在研究的第0 - 1周、3 - 4周和12 - 13周期间,通过植入含有5 - 溴 - 2'-脱氧尿苷的渗透泵来研究复制性DNA合成。DEHA处理1周后,给予2.5%和4.0% DEHA的大鼠以及给予0.6 - 2.5% DEHA的小鼠的肝细胞标记指数值增加。虽然DEHA处理4周和13周并未增加大鼠的标记指数值,但在给予1.2%和2.5% DEHA的小鼠中观察到复制性DNA合成的持续刺激。本研究结果表明DEHA对肝脏的影响存在物种差异,即在某些剂量水平下,DEHA可在小鼠肝脏而非大鼠肝脏中产生对复制性DNA合成的持续刺激。与肝脏过氧化物酶体增殖的刺激程度相比,持续的细胞复制与在雌性小鼠而非雌性大鼠中进行的DEHA慢性研究中观察到的肝肿瘤形成具有更好的相关性。